ResMed Astral 100 and 150 Ventilators Recall
Areazine synthesizes this MHRA medicine alert directly from MHRA's official public data feed. See our methodology for full source attribution and refresh cadence.
ResMed has issued a Field Safety Notice for Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024 due to a fault that can cause unexpected interruption of ventilation therapy.
What this MHRA medicine alert tells you, and what most readers miss
This notice was issued by MHRA on August 17, 2026 and geographically references United Kingdom. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Medicine Alerts - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, mhra, ventilators.
What Happened
ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected interruption of ventilation therapy, leading to potential patient harm.
Which Products Are Affected
ResMed Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024.
What You Should Do
Patients and healthcare providers should follow the instructions in the Field Safety Notice issued by ResMed.
Why This Matters
The alert is classified as high severity due to the risk of unexpected interruption of ventilation therapy.
Source
MHRA National Patient Safety Alert (NatPSA/2026/004/MHRA)
Original source: MHRA Official Notice ↗
Related Medicine Alerts
All Medicine Alerts →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this MHRA medicine alert: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,030 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 17, 2026.
Frequently Asked Questions
Common questions about this MHRA medicine alert.